Method for obtaining and culturing Eustachian tube mucous membrane epithelial cells

Through the separation of discarded materials during surgery and gas-liquid interface culture technology of contralateral skull base tumor patients, human primary Eustachian tube mucosal epithelial cells were successfully cultivated, solving the problem of obtaining human cells in the existing technology and providing suitable human resources The tools for cell research fill the research gap.

CN119020264APending Publication Date: 2024-11-26PEKING UNION MEDICAL COLLEGE HOSPITAL
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411420430.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-12
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

It is difficult to obtain sufficient amounts of living human Eustachian tube mucosal epithelial cells for research in the prior art, and the existing culture methods have problems of genera differences and insufficient targeting.

Method used

By isolating discarded materials during the surgery of contralateral skull base tumor patients, human primary Eustachian tube mucosal epithelial cells were successfully cultivated using gas-liquid interface culture technology, and a differentiation model was established by simulating the internal environment.

Benefits of technology

It has achieved efficient culture and differentiation of human primary Eustachian tube epithelial cells, filled the gap in research tools, and provided a more suitable microscopic pathological mechanism research tool, suitable for the field of temporal bone ventilation and drainage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020264A_ABST
    Figure CN119020264A_ABST
Patent Text Reader

Abstract

The invention relates to a method for obtaining and culturing Eustachian tube mucosa epithelial cells, which comprises the following steps: 1) obtaining Eustachian tube mucosa; 2) primary culture of Eustachian tube epithelial cells; 3) subculture of Eustachian tube epithelial cells; and (4) culturing the Eustachian tube epithelial cells on a gas-liquid interface on the Transwell.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biomedicine and relates to the living sampling and in vitro culture of Eustachian tube mucosal epithelial cells. Background Art

[0002] The Eustachian tube is a tube structure that connects the lateral wall of the nose to the anterior and inferior wall of the middle ear tympanic cavity. It is an organ (some scholars call it a system) composed of a tube cavity with mucous membrane, cartilage, surrounding soft tissue, para-tuberal muscles (tensor tympani, tensor veli palatini, levator veli palatini and eustachian tube pharyngeal muscle) and bony support (sphenoid groove and inner pterygoid plate). The physiological functions of the Eustachian tube include: ① ventilation and balance of middle ear air pressure; ② clearing middle ear mucosal secretions; ③ middle ear soundproofing; ④ preventing retrograde infection of nasopharyngeal pathogens.

[0003] The Eustachian tube is covered by respiratory epithelium, and the cells that make up it include: columnar ciliated cells (accounting for >80% under normal conditions), goblet cells, and some squamous cells near the transitional part of the nasopharynx. Serous and mucous glands are mainly distributed in the submucosal layer on the dorsal and medial side of the Eustachian tube. The epithelial cells (ciliated cells and goblet cells) and glandular cells of the mucosa can secrete immune molecules, together forming the inherent immune barrier of the Eustachian tube. Columnar ciliated cells are mainly distributed on the inner and lower walls of the Eustachian tube. Each cell has about 200 cilia on the top, which swing rhythmically toward the nasopharyngeal opening at a frequency of about 11 to 22 times per second, transporting the mucus on the top of the cilia containing various protein particles to the nasopharyngeal opening like a conveyor belt. When any of the above clearance mechanisms is obstructed, it can lead to diseases that seriously affect the patient's quality of life, such as secretory otitis media, middle ear cholesteatoma, etc., all of which have no radical treatment for the cause because the mechanism is unclear.

[0004] Since the bony part of the Eustachian tube is located below the petrous part of the temporal bone, and the cartilaginous part that extends forward to the nasopharyngeal cavity is located in the parapharyngeal space, the entire lumen is located deep and is adjacent to important tissue structures, and conventional surgery is difficult to obtain sufficient living tissue for research. Therefore, existing research on Eustachian tube epithelial cells mostly uses tissue separation after killing experimental animals to obtain the mucosal epithelium of the mouse Eustachian tube or other middle ear structures and culture them in vitro. However, the present invention uses the infratemporal fossa approach to utilize the discarded materials from the surgery of patients with contralateral skull base tumors, successfully obtains and cultures human Eustachian tube mucosal epithelial cells, and does not cause additional trauma to the patients.

[0005] At present, there are no reports on the cultivation of primary human Eustachian tube epithelial cells worldwide. The present invention uses freshly isolated Eustachian tube mucosa from the human body and utilizes the gold standard for respiratory epithelial cell culture, air-liquid interface culture, to create for the first time this type of primary cell line based on human organs. Compared with previously reported mouse cell lines, there is no species difference and it is more suitable for microscopic pathological and physiological mechanism research. Compared with the previous method of using the middle ear mucosa of human fetuses that have been arrested as raw materials, the mature and differentiated Eustachian tube cartilage mucosa is more specifically isolated and cultured. The invention is carried out under conditions that highly simulate the in vivo environment. By establishing an in vitro differentiation model of Eustachian tube ciliated epithelial cells, it fills the gap in research tools in the field of temporal bone ventilation and drainage, and can serve as a strong foundation for revealing its physiological and pathological mechanisms from a microscopic perspective. Summary of the invention

[0006] The purpose of the present invention is to provide a method for obtaining, culturing and applying human primary Eustachian tube mucosal epithelial cells, so as to fill the current gap of this type of cells as an important research tool.

[0007] The purpose of the present invention is achieved through the following technical solutions:

[0008] The method for obtaining and culturing Eustachian tube epithelial cells of the present invention comprises the following steps:

[0009] 1) Obtaining the Eustachian tube mucosa;

[0010] 2) Primary culture of Eustachian tube epithelial cells;

[0011] 3) Subculture of Eustachian tube epithelial cells;

[0012] 4) Eustachian tube epithelial cells were cultured at the air-liquid interface on Transwell.

[0013] Wherein, the method for obtaining the Eustachian tube mucosa in step 1) is as follows:

[0014] The Eustachian tube was closed by B-type or C-type approach in the infratemporal fossa. The tissue removed during the operation was washed with physiological saline and placed in a centrifuge tube containing RPMI-1640 and three antibodies to remove excess cartilage and connective tissue. The fragments were chopped, washed, centrifuged, collected, and washed once with PBS buffer. After removing the supernatant, ACF Enzymatic Dissociation Solution was added and transferred to a 6-well plate for digestion overnight. ACF Enzyme Inhibition Solution was then added to terminate the digestion. The digestion solution was filtered through cell sieves with pore sizes of 70μm and 40μm in turn.

[0015] The primary culture method of step 2) Eustachian tube epithelial cells is as follows: the filtrate is centrifuged at 350 g for 5 min, the supernatant is discarded, and 4 mL of Complete PneumaCult TM -Ex Plus Medium culture medium was placed in a 37°C 5% CO2 incubator and the culture medium was replaced every 2-3 days.

[0016] Wherein, the method for subculturing the Eustachian tube epithelial cells in step 3) is as follows: subculturing is performed when the cell confluence reaches 50-60% under a microscope; the cells are washed once with PBS; the cells are incubated with ACF Enzymatic Dissociation Solution at 37°C for 7-8 minutes; after terminating the digestion, the digestion solution is collected and centrifuged at 350g for 5 minutes; the supernatant is discarded, and complete PneumaCult® preheated to 15-25°C is added to the cell pellet at a volume ratio of 1:2 or 1:3. TM ExPlus Medium, placed in a 37℃ 5% CO2 incubator; wash cells once with 2mL PBS; incubate cells with ACF Enzymatic Dissociation Solution at 37℃ for 7-8 minutes; after terminating digestion, collect the digestion solution and centrifuge at 350g for 5 minutes; discard the supernatant, add complete PneumaCult preheated to 15-25℃ in a volume ratio of 1:2 or 1:3 to the cell pellet TM Ex Plus Medium and count the cells.

[0017] In step 4), the method for culturing the Eustachian tube epithelial cells at the air-liquid interface on the Transwell is as follows: 1 mL of complete PneumaCult TM Ex Plus Medium; add 10×104 cells and 0.5 mL PneumaCult TM -Ex Plus Medium; Place the Transwell in a 37℃ 5% CO2 constant temperature incubator and culture. Replace the culture medium in the upper and lower chambers every 2-3 days until the cells fill the chambers. Remove the culture medium in the upper and lower chambers and add 1 mL of PneumaCult preheated to 15-25℃ to the lower chamber only. TM-ALIMaintenance Medium; wash the cell surface of the upper chamber with PBS buffer every 2-3 days, and replace the culture medium in the lower chamber. When the cells are transferred to ALI culture for more than 28 days, densely distributed cilia can be seen on the top of the cells, and discontinuously distributed lumen-like structures can be seen for more than 35 days, which can be used for microscopic image acquisition and data measurement.

[0018] Preferably, in step 1), the method for obtaining the Eustachian tube mucosa is as follows:

[0019] (1) Patients whose lateral skull base tumors invade the petrous apex and / or the slope, and even form intracranial and extracranial communicating masses, need to undergo Eustachian tube resection and closure via the infratemporal fossa type B or C approach. If the preoperative evaluation of Eustachian tube function is normal, there is no tumor invasion in the Eustachian tube area during the operation, and the lumen surface of the Eustachian tube cartilage can be completely separated while ensuring the activity of the mucosa, the discarded Eustachian tube specimens during the operation can be used for the present invention;

[0020] (2) The tissue removed during surgery was washed with saline and placed in a centrifuge tube containing RPMI-1640 and three antibodies.

[0021] (3) Remove excess cartilage and connective tissue, chop them up and wash them

[0022] (4) After centrifugation, the fragments were collected and washed once with PBS buffer;

[0023] (5) After removing the supernatant, add ACF Enzymatic Dissociation Solution and transfer to a 6-well plate for overnight digestion. Then add ACF Enzyme Inhibition Solution to terminate the digestion.

[0024] (6) Filter the digestion solution through cell sieves with pore sizes of 70 μm and 40 μm respectively;

[0025] Wherein, the primary culture method of Eustachian tube epithelial cells in step 2) is as follows:

[0026] The filtrate was centrifuged at 350g for 5 min, the supernatant was discarded and 4 mL of Complete PneumaCult was added TM -Ex Plus Medium culture medium, placed in a 37°C 5% CO2 incubator;

[0027] (7) Replace the culture medium every 2-3 days;

[0028] Wherein, the subculture method of step 3) Eustachian tube epithelial cells is as follows:

[0029] (8) When the cell confluence reaches 50-60% under a microscope, subculture is performed.

[0030] (9) Wash the cells once with PBS;

[0031] (10) Incubate the cells with ACF Enzymatic Dissociation Solution at 37°C for 7-8 minutes. After digestion is terminated, collect the digestion solution and centrifuge it at 350 g for 5 minutes.

[0032] (11) Discard the supernatant and add complete PneumaCult® preheated to 15-25°C in a volume ratio of 1:2 or 1:3 to the cell pellet. TM Ex Plus Medium, cultured in a 37℃ 5% CO2 incubator;

[0033] (12) Wash the cells once with 2 mL PBS;

[0034] (13) Incubate the cells with ACF Enzymatic Dissociation Solution at 37°C for 7-8 minutes. After digestion is terminated, collect the digestion solution and centrifuge it at 350 g for 5 minutes.

[0035] (14) Discard the supernatant and add complete PneumaCult® preheated to 15-25°C in a volume ratio of 1:2 or 1:3 to the cell pellet. TM Ex Plus Medium, cells were counted;

[0036] Wherein, in step 4), the method for culturing Eustachian tube epithelial cells at the air-liquid interface on Transwell is as follows:

[0037] (15) Add 1 mL of complete PneumaCult® to the lower chamber of the 12 mm wide Transwell. TM Ex Plus Medium;

[0038] (16) Add 10×10 4 cells, and 0.5 mL PneumaCult TM -ExPlus Medium;

[0039] (17) The Transwell was placed in a 37°C 5% CO2 constant temperature incubator and the culture medium in the upper and lower chambers was replaced every 2-3 days until the cells filled the chambers.

[0040] (18) Aspirate the culture medium in the upper and lower chambers and add 1 mL of PneumaCult preheated to 15-25°C to the lower chamber only. TM-ALI Maintenance Medium;

[0041] (19) The cell surface of the upper chamber was washed with PBS buffer every 2-3 days, and the culture medium of the lower chamber was replaced.

[0042] (20) After being transferred to ALI culture for more than 28 days, densely distributed cilia can be seen on the top of the cells, and discontinuously distributed lumen-like structures can be seen after more than 35 days, which can be used for microscopic-scale image acquisition and data measurement.

[0043] Existing culture methods and reagents are only reported for in vitro culture of respiratory mucosal epithelial cells from other parts, such as culturing nasal mucosa, bronchial, and alveolar cells for respiratory system research. By improving the air-liquid interface (ALI) culture method of nasal mucosal epithelial cells, the world's first successful in vitro culture system of primary Eustachian tube epithelial cells using human living materials as a source was established.

[0044] The beneficial effects of the present invention are as follows: through the method for isolating Eustachian tube epithelial cells of the present invention, three samples have been successfully cultured in vitro, and mature differentiated cells can be obtained smoothly after being cultured at the air-liquid interface for more than 30 days. The primary Eustachian tube epithelial cells can maintain good cell morphology and vitality within two generations of in vitro culture, and can be used as a functional model for subsequent research applications.

[0045] The following is an explanation of the terms of the present invention:

[0046] PBS: (Phosphate Buffered Saline) is a balanced salt solution. The main components are Na2HPO4, KH2PO4, NaCl and KCl. PBS is generally used as a solvent for various cell culture applications, such as washing cells before dissociation, transporting cells or tissues, diluting cells for counting and preparing reagents.

[0047] Penicillin-Streptomycin-Amphotericin B Mixed Solution: Penicillin-Streptomycin-Amphotericin B Solution 100X is a triple antibody specifically used for cell culture. It is added to the cell culture medium to prevent contamination by foreign bacteria. The antibacterial spectrum covers bacteria, fungi and yeast.

[0048] RPMI-1640 medium (Roswell Park Memorial Institute 1640 medium): purchased from ThermoFisher. This medium is suitable for culturing a variety of mammalian cells, including HeLa cells, Jurkat cells, MCF-7 cells, PC12 cells, PBMC cells, astrocytes and cancer cells.

[0049] Animal Component-Free Cell Dissociation Kit (including ACF Enzymatic Dissociation Solution and ACF Enzyme Inhibition Solution): purchased from STEMCELL Technologies, this is an animal component-free cell dissociation kit. The kit contains ACF enzymatic dissociation solution and ACF enzyme inhibition solution, which are specifically used for the dissociation and subculture of human stem cells and progenitor cells. The ACF enzymatic dissociation solution in the kit contains mild proteases, such as trypsin or collagenase, which can effectively dissociate cells without damaging the cell membrane. The ACF enzyme inhibition solution contains soybean trypsin inhibitor or other types of protease inhibitors, which can quickly neutralize the enzyme activity in the enzymatic dissociation solution, thereby protecting the cells.

[0050] PneumaCult TM -Ex Plus Medium: Purchased from STEMCELL Technologies, PneumaCult TM -ExPlus Medium is a serum-free and bovine pituitary extract (BPE)-free cell culture medium that has been shown to support the expansion of primary human respiratory and nasal epithelial cells in culture.

[0051] PneumaCult TM -ALI Medium with 12mm Inserts: Purchased from STEMCELL Technologies, PneumaCult TM -ALI medium is a serum-free and BPE-free medium for culturing human respiratory epithelial cells at the air-liquid interface (ALI). Respiratory epithelial cells cultured in this way can be transformed into ciliated pseudostratified columnar epithelium, which has morphological and functional characteristics similar to those in the human respiratory tract. TM -ALI set includes 12mm

[0052] Hydrocortisone Stock Solution: Purchased from STEMCELL Technologies, hydrocortisone solution is used as a cell culture supplement in the present invention and in the preparation of PneumaCult TM Add to culture medium.

[0053] Heparin Solution: purchased from STEMCELL Technologies. Heparin solution is used as a cell culture supplement in the present invention.TM -ALI Maintenance Medium.

[0054] Cell culture incubator: Thermo SCIENTIFIC 3131

[0055] Microscope: Olympus CKX53

[0056] Centrifuge: Baiyang low speed centrifuge

[0057] 70μm and 40μm cell sieves: Guangzhou Jiete Biotechnology. BRIEF DESCRIPTION OF THE DRAWINGS

[0058] Figure 1 : Experimental Example 1 Eustachian tube cartilage separated during surgery

[0059] Figure 2 : Experimental Example 1 After 7 days of culture of primary Eustachian tube epithelial cells, the cells showed clonal growth (microscope × 100)

[0060] Figure 3 : Experimental Example 1 After 16 days of culture, primary Eustachian tube epithelial cells formed a dense cell layer and were transferred to air-liquid interface culture (microscope ×100)

[0061] Figure 4 Experimental Example 1: Cell morphology of Eustachian tube epithelial cells transferred to air-liquid interface culture on the 42nd day, 80% of the cells had cilia with swinging ability on the surface (microscope × 100)

[0062] Figure 5 Experimental Example 2: Cell morphology of Eustachian tube epithelial cells transferred to air-liquid interface culture on the 17th day (microscope × 100)

[0063] Figure 6 : Experimental Example 2 Cell morphology of Eustachian tube epithelial cells transferred to air-liquid interface culture on the 35th day, with multiple cavity-like structures formed between cells (microscope ×100)

[0064] Figure 7 : Experimental Example 3 Cell morphology of Eustachian tube epithelial cells transferred to air-liquid interface culture on the 21st day, HE staining (microscope, see the scale bar in the lower right corner)

[0065] Figure 8 : Experimental Example 3 Cell morphology of Eustachian tube epithelial cells transferred to air-liquid interface culture on the 35th day, AB-PAS staining (microscope, see the scale bar in the lower right corner)

[0066] Fig. 9 : Experimental Example 3: On the 35th day after the Eustachian tube epithelial cells were transferred to the air-liquid interface culture, the morphology of cell surface cilia under transmission electron microscopy (see the scale bar in the lower right corner for transmission electron microscopy)

[0067] Fig.10 : Experimental Example 2 Immunofluorescence staining of Eustachian tube epithelial cells transferred to air-liquid interface culture on the 17th day. Specific antibodies FOXJ1 (yellow), MUC5B (red), and P63 (green) labeling can confirm that the cells are of ciliated epithelial origin (see the scale bar in the lower left corner for details of the microscope). DETAILED DESCRIPTION

[0068] The present invention is further illustrated by the following examples.

[0069] The product and preparation method of the present invention are further described below in conjunction with specific examples, but the present invention is not limited to the following examples. The methods are conventional methods unless otherwise specified. The raw materials and reagents used above are all known products and can be purchased from the official website of the supplier.

[0070] Embodiment 1,

[0071] This embodiment provides a Eustachian tube mucosal epithelial cell, and the specific method for obtaining it is as follows:

[0072] 1. Obtain the Eustachian tube mucosa:

[0073] (1) Because the patient's intracranial and extracranial communicating tumor (giant cell reparative granuloma) invaded the right middle cranial fossa, temporal bone, maxilla, temporomandibular joint, lateral wall of maxillary sinus, parapharyngeal, lateral pterygoid muscle, external auditory canal, internal carotid canal and parotid gland, involving a large number of important structures, a one-time resection may lead to severe intracranial infection and life-threatening functional disorders, so staged surgical treatment was required. The surgeon removed the Eustachian tube during the first-stage operation through the infratemporal fossa B-type approach and permanently closed the area. The patient's preoperative evaluation showed that the Eustachian tube function was normal, and intraoperative exploration of the Eustachian tube area showed no tumor invasion. When admitted to the hospital, he had signed an informed consent form that the intraoperative specimens might be used for clinical research, so the discarded Eustachian tube cartilage was used for epithelial cell culture;

[0074] (2) Immediately rinse the surface bleeding, mucus and necrotic tissue of the excised Eustachian tube cartilage with a large amount of sterile saline; the treated tissue was placed in RPMI-1640 culture medium containing three antibodies under sterile conditions.

[0075] (3) The formula is: 5 mL 100× penicillin-streptomycin-amphotericin B + 500 mL RPMI-1640 culture medium.

[0076] 2. Primary culture of Eustachian tube epithelial cells:

[0077] (1) Maintaining the transport condition at 0-4°C, the specimen was transported to the cell culture room within 6 hours after ex vivo explantation, and then rinsed with PBS buffer. The mucosal surface of the Eustachian tube was peeled off and cut into pieces, and the pieces were collected by centrifugation at 350g for 5 minutes.

[0078] Wash once with PBS;

[0079] (2) After the supernatant of the centrifuged sample was removed, 2 mL of ACF Enzymatic Dissociation Solution was added to the cell pellet and the plate was transferred to a 6-well plate. The plate was digested overnight in a constant temperature incubator at 37°C and 5% CO2, and then 2 mL of ACF Enzyme Inhibition Solution was added to terminate the digestion.

[0080] (3) Filter the digestion solution through cell sieves with pore sizes of 70 μm and 40 μm to remove residual tissue fragments;

[0081] (4) The filtrate was centrifuged at 350 g for 5 min to collect the Eustachian tube mucosal epithelial cells and add 4 mL of Complete PneumaCult TM -Ex Plus Medium culture medium, placed in a 37℃ 5% CO2 incubator;

[0082] (5)Complete PneumaCult TM -Ex Plus Medium culture medium formula: 10mL PneumaCult TM -Ex Plus 50×Supplement+0.5mL Hydrocortisone Stock Solution+5mL 100×Penicillin-Streptomycin-Amphotericin B+490mL PneumaCult TM -Ex Plus Basal Medium

[0083] (6) The culture medium was replaced every 2-3 days. When the cell confluence reached 50-60% under a microscope, subculture was performed.

[0084] 3. Subculture of Eustachian tube mucosal epithelial cells:

[0085] (1) PBS, complete PneumaCult TM Pre-warm Ex Plus Medium and ACF Cell Dissociation Kit to room temperature (15-25°C);

[0086] (2) Wash the cells once with 2 mL of PBS;

[0087] (3) Add 2 mL of ACF Enzymatic Dissociation Solution and incubate at 37°C for 7-8 minutes;

[0088] (4) Add 2 mL of ACF Enzyme Inhibition Solution to terminate digestion and collect the digestion solution into a 15 mL centrifuge tube;

[0089] (5) Centrifugation at 350 g for 5 minutes;

[0090] (6) After centrifugation, the supernatant was discarded and complete PneumaCult was added to the cell pellet at a volume ratio of 1:2. TM Ex Plus Medium, cultured in a 37°C 5% CO2 incubator;

[0091] 4. Proliferation and culture of Eustachian tube epithelial cells:

[0092] (1) PBS, complete PneumaCult TM Pre-warm Ex Plus Medium and ACF Cell Dissociation Kit to room temperature (15-25°C);

[0093] (2) Wash the cells once with 2 mL of PBS;

[0094] (3) Add 2 mL of ACF Enzymatic Dissociation Solution and incubate at 37°C for 7-8 minutes;

[0095] (4) Add 2 mL of ACF Enzyme Inhibition Solution to terminate digestion and collect the digestion solution into a 15 mL centrifuge tube;

[0096] (5) Centrifugation at 350 g for 5 minutes;

[0097] (6) After centrifugation, discard the supernatant and add complete PneumaCult® in a volume ratio of approximately 1:2 or 1:3 to the cell pellet. TM Ex Plus Medium, cells were counted;

[0098] (7) Add 1 mL of complete PneumaCult® to the lower chamber of the Transwell. TM Ex Plus Medium;

[0099] (8) Add 10×10 4 cells, and 0.5 mL PneumaCult TM -Ex Plus Medium;

[0100] (9) Place the cells in a 37°C 5% CO2 constant temperature incubator and culture. Replace the culture medium in the upper and lower chambers every 2-3 days until the cells fill the chambers.

[0101] 5. Air-liquid interface culture of Eustachian tube epithelial cells:

[0102] (1) Prepare your own PneumaCult in advance TM -ALI Maintenance Medium, formula: 9.83mL PneumaCult TM -ALI Complete Base Medium+100μLPneumaCult TM -ALIMaintenance Supplement+20μL Heparin Solution+50μL Hydrocortisone Stock Solution+100μL 100× Penicillin-Streptomycin-Amphotericin B Mixed Solution;

[0103] (2) PBS, PneumaCult TM -Preheat ALI Maintenance Medium and ACF Cell Dissociation Kit to room temperature (15–25°C);

[0104] (3) Aspirate the culture medium in the upper and lower chambers and add 1 mL of PneumaCult to the lower chamber only. TM -ALIMaintenanceMedium;

[0105] (4) Wash the cell surface of the upper chamber with 0.5 mL of PBS every 2-3 days to wash off the mucus and replace the culture medium in the lower chamber.

[0106] (5) After 28 days of ALI culture, densely distributed cilia can be seen on the top of the cells, and after 35 days, discontinuously distributed lumen-like structures can be seen, which can be used for microscopic image acquisition and data measurement.

[0107] Example 2

[0108] This embodiment provides a Eustachian tube mucosal epithelial cell, and the specific method for obtaining it is as follows:

[0109] 1. The well-differentiated chondrosarcoma suffered by this patient is a malignant lesion located at the left skull base, compressing the affected internal carotid artery and invading the cavernous sinus. The tumor should be removed as soon as possible and as completely as possible. Because the lesion involves the petrous apex, slope to the occipital bone, the Eustachian tube was removed during the C-type approach to the infratemporal fossa during surgery, and the area was permanently closed. The patient's preoperative evaluation showed that the Eustachian tube function was normal, and intraoperative exploration of the tumor only invaded the upper air chamber of the Eustachian tube without invading the mucosa. In addition, the patient had signed an informed consent form when he was admitted to the hospital that the intraoperative specimens might be used for clinical research, so the discarded Eustachian tube cartilage was used for epithelial cell culture.

[0110] 2. After centrifugation at 350g for 5 minutes, collect the Eustachian tube mucosal epithelial cells and add 4 mL of Complete PneumaCult TM -Ex Plus Medium culture medium was placed in a 4°C 5% CO2 incubator overnight; the culture medium was replaced every 2-3 days, and subculture was performed when the cell confluence reached 70-80% under a microscope.

[0111] 3 After centrifugation, discard the supernatant and add complete PneumaCult TM Ex Plus Medium, cultured in a 37°C 5% CO2 incubator;

[0112] Embodiment 3,

[0113] This embodiment provides a Eustachian tube mucosal epithelial cell, and the specific method for obtaining it is as follows:

[0114] 1. After removing the supernatant from the centrifuged sample, transfer the cell pellet to a 15 ml centrifuge tube, add 2 ml of 1 mg / ml collagenase XIV, and digest overnight in a constant temperature incubator at 4°C and 5% CO2;

[0115] 2. After centrifugation at 350g for 5 min, the filtrate was collected to collect the Eustachian tube mucosal epithelial cells, 4 mL of BEDM medium was added, and the cells were placed in a 4°C 5% CO2 incubator overnight;

[0116] 3. Bronchial epithelial cell growth medium (BEDM) and cytokine (BEGM SingleQuots) kits were purchased from Lonza Bioscience. The medium formula is: 10 mL PneumaCult TM-Ex Plus 50×Supplement+0.5mL HydrocortisoneStock Solution+5mL 100×Penicillin-Streptomycin-Amphotericin B+490mL PneumaCult TM -Ex Plus Basal Medium

[0117] Note: The sources of reagents and materials used in the experiment are as follows:

[0118] ① Collagenase XIV: Protease from Streptomyces griseus Type XIV, >=3.5units / mgsolid, purchased from Sigma-Aldrich. This type of protease is extracted from Streptomyces griseus and is a mixture of at least three proteolytic activities including extracellular serine proteases. Serine proteases show broad substrate specificity and can be used for extensive or complete protein degradation. This protease mixture is highly non-specific and can digest casein to a degree of >70% as a single amino acid. The enzyme prefers to hydrolyze peptide bonds on the carboxyl side of glutamic acid or aspartic acid.

[0119] ②BEGM TM Bronchial Epithelial Cell Culture BulletKit TM The set includes: BEBMTM bronchial epithelial cell basal medium and BEGMTM bronchial epithelial cell SingleQuotsTM supplements and growth factors. Every 500ml BEGM bronchial epithelial cell basal medium needs to add 6ml of supplements and growth factors, including: 2.00mL bovine pituitary extract (BPE), 0.50mL insulin, 0.50mL hydrocortisone, and GA-1000

[0120] (Gentamicin Sulfate-Amphotericin B) 0.50mL, Retinoic Acid 0.50mL, Transferrin 0.50mL, T3 Thyroxine 0.50mL, Epinephrine 0.50mL, Human Epidermal Growth Factor hEGF 0.50mL. This medium is serum-free and is designed to support the growth of primary human bronchial epithelial cells. It has been reported to be used to culture a variety of respiratory epithelial cell lines from normal and diseased tissues.

[0121] The above description is only a preferred embodiment of the present invention. It should be noted that the embodiments of the present invention are not limited to the embodiments. Without departing from the principle of the present invention, several changes, modifications, substitutions, combinations, and simplifications can be made, all of which should be equivalent replacement methods, and these should also be regarded as the scope of protection of the present invention.

Claims

1. A method for obtaining and culturing Eustachian tube mucosal epithelial cells, characterized in that: The method comprises the following steps: 1) Obtaining the Eustachian tube mucosa; 2) Primary culture of Eustachian tube epithelial cells; 3) Subculture of Eustachian tube epithelial cells; 4) Eustachian tube epithelial cells were cultured at the air-liquid interface on Transwell.

2. The method according to claim 1, characterized in that: in, Step 1) The method for obtaining the Eustachian tube mucosa is as follows: The Eustachian tube was closed by B-type or C-type approach in the infratemporal fossa. The tissue removed during the operation was washed with physiological saline and placed in a centrifuge tube containing RPMI-1640 and three antibodies to remove excess cartilage and connective tissue. The fragments were chopped, washed, centrifuged, collected, and washed once with PBS buffer. After removing the supernatant, ACF Enzymatic Dissociation Solution was added and transferred to a 6-well plate for digestion overnight. ACF Enzyme Inhibition Solution was then added to terminate the digestion. The digestion solution was filtered through cell sieves with pore sizes of 70μm and 40μm in turn.

3. The method according to claim 1, characterized in that in, Step 2) Primary culture of Eustachian tube epithelial cells is as follows: centrifuge the filtrate at 350 g for 5 min, discard the supernatant and add 4 mL of Complete PneumaCult TM -Ex Plus Medium culture medium was placed in a 37°C 5% CO2 incubator and the culture medium was replaced every 2-3 days.

4. The method according to claim 1, characterized in that: in, Step 3) The subculture method of Eustachian tube epithelial cells is as follows: subculture when the cell confluence reaches 50-60% under a microscope; wash the cells once with PBS; incubate the cells with ACF Enzymatic Dissociation Solution at 37°C for 7-8 minutes; after terminating the digestion, collect the digestion solution and centrifuge at 350g for 5 minutes; discard the supernatant, and add complete PneumaCult preheated to 15-25°C in a volume ratio of 1:2 or 1:3 to the cell pellet TM Ex Plus Medium, placed in a 37℃ 5% CO2 incubator; wash cells once with 2mL PBS; incubate cells with ACF Enzymatic Dissociation Solution at 37℃ for 7-8 minutes; after terminating digestion, collect the digestion solution and centrifuge at 350g for 5 minutes; discard the supernatant, add complete PneumaCult preheated to 15-25℃ in a volume ratio of 1:2 or 1:3 to the cell pellet TM Ex Plus Medium and count the cells.

5. The method according to claim 1, characterized in that in, Step 4) The method for culturing Eustachian tube epithelial cells at the air-liquid interface on Transwell is as follows: 1 mL of complete PneumaCult TM Ex Plus Medium; add 10×10 4 cells, and 0.5 mL PneumaCult TM -Ex Plus Medium; Place the Transwell in a 37°C 5% CO2 constant temperature incubator and culture. Replace the culture medium in the upper and lower chambers every 2-3 days until the cells fill the chambers. Remove the culture medium in the upper and lower chambers and add 1 mL of PneumaCult preheated to 15-25°C to the lower chamber only. TM -ALIMaintenance Medium; wash the cell surface of the upper chamber with PBS buffer every 2-3 days, and replace the culture medium in the lower chamber. When the cells are transferred to ALI culture for more than 28 days, densely distributed cilia can be seen on the top of the cells, and discontinuously distributed lumen-like structures can be seen for more than 35 days, which can be used for microscopic image acquisition and data measurement.

Citation Information

Patent Citations

  • Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same

    CN105101965A

  • Establishment and application of porcine respiratory tract epilhelium in-vitro 3D model

    CN105734008A

  • Nasal mucosa organoid culture medium and culture method

    CN111117946A

  • Preparation method and use method of reagent for detecting free heme of nasopharyngeal mucosa cells

    CN112858269A

  • Chicken primary cartilage cell isolated culture and identification method

    CN112877283A